Benefits
Cognitive Function (Mixed Evidence)
The often repeated claim that pregnenolone improved work performance in factory workers comes from uncited 1940s research that is not referenced here and does not meet modern standards. The modern human research is not in healthy people: it was done in people with schizophrenia who were already taking prescription antipsychotic medication, at doses far above what supplement labels suggest, and in one of those trials pregnenolone was given together with L-theanine, so that result cannot be credited to pregnenolone alone. There is no good evidence that pregnenolone improves memory or thinking in healthy adults.
Bipolar Disorder Adjunct (Research)
A randomized, placebo-controlled trial gave up to 500 mg a day of pregnenolone to 80 people with bipolar depression for 12 weeks, on top of their usual prescription treatment, and depression scores improved more than with placebo. That dose is many times a typical supplement dose, and everyone in the trial had a diagnosed illness and was under psychiatric care. This says nothing about mood in a healthy person, and pregnenolone is not a treatment for depression. Nobody should add it to psychiatric medication without talking to their doctor.
Schizophrenia Cognitive Symptoms (Research)
Two randomized trials are cited, both in people already taking prescription antipsychotic medication. One added pregnenolone to risperidone in 40 women with schizophrenia and found lower total and negative symptom scores than placebo. The other, an 8 week trial, gave pregnenolone together with L-theanine, so its result cannot be credited to pregnenolone by itself. Results across the wider literature are mixed. This is supervised medical research in a serious diagnosed illness and is not a reason for a healthy person to take pregnenolone.
Joint Comfort (Historical, Uncited Reports)
Uncited reports from the 1940s and 1950s described less joint pain with pregnenolone, but that work is not referenced here and does not meet modern standards. The line of research was largely abandoned once cortisone type anti-inflammatory drugs arrived, and there is essentially no modern research. Pregnenolone is not a treatment for arthritis or any other disease.
Theoretical Anti-Aging / Hormone Precursor Support
Used in some integrative anti-aging protocols based on age-related decline in pregnenolone and downstream hormones. Insufficient evidence for anti-aging claims; reasonable mechanism but clinical translation unclear.
Mechanism of action
Steroidogenic Pathway Precursor
Pregnenolone is the first steroid hormone synthesized from cholesterol — by CYP11A1 (cholesterol side-chain cleavage enzyme). All other steroid hormones (progesterone, cortisol, aldosterone, DHEA, testosterone, estrogens) derive from pregnenolone. Taking pregnenolone adds more of this starting material, but how much of it a given person converts into which hormone is not predictable, and raising a hormone is not automatically a benefit.
Direct Neurosteroid Activity
Pregnenolone (and pregnenolone sulfate) acts directly on GABA-A and NMDA receptors — neurosteroid effects independent of conversion to other hormones. May contribute to cognitive and mood effects.
Pregnenolone Sulfate (PS) Effects
Pregnenolone is sulfated in body to PS — a negative allosteric modulator of GABA-A and positive modulator of NMDA receptors. This receptor activity comes from laboratory and animal work rather than human trials, so it describes a possible mechanism, not a proven effect in people.
Variable Downstream Hormone Production
Supplemental pregnenolone is converted to varying amounts of progesterone, cortisol, DHEA, testosterone, estrogens depending on individual enzymatic activity. Effects differ between individuals — explains variable clinical responses.
Clinical trials
Randomized, double-blind, placebo-controlled trial of pregnenolone at up to 500 mg per day versus placebo in 80 people with bipolar depression over 12 weeks, added on top of their existing prescription treatment.
80 adults with diagnosed bipolar depression, under psychiatric care and on existing prescription treatment.
Depression scores improved more than with placebo. This was research in a diagnosed psychiatric illness, at a dose far above what supplement labels suggest, with pregnenolone added on top of standard treatment rather than replacing it. It does not show what pregnenolone does for everyday low mood in a healthy person.
Two randomized, double-blind, placebo-controlled trials, both adding pregnenolone to prescription antipsychotic medication rather than testing it on its own. One added pregnenolone to risperidone in 40 women with schizophrenia. The other ran 8 weeks and gave pregnenolone combined with L-theanine.
40 women with schizophrenia taking risperidone in one trial, and people with schizophrenia on antipsychotic therapy in the other.
In the risperidone trial, total and negative symptom scores fell more than with placebo. In the 8 week trial, negative symptoms and anxiety improved, but pregnenolone was given with L-theanine, so that result cannot be credited to pregnenolone alone. Results across the wider literature are mixed. Both trials describe supervised medical treatment of a serious illness, not consumer supplement use.